REDUCE-IT
A study that tested 4 grams of EPA in people with heart disease or diabetes and elevated triglycerides, showing spectacular results in reducing cardiovascular events.
Save the 3 videos on REDUCE-IT to your own pod.
Sign up free to keep building your knowledge base on REDUCE-IT as more episodes are added.
Videos Mentioning REDUCE-IT
#134 - James O’Keefe, M.D.: Preventing cardiovascular disease and the risk of too much exercise
Peter Attia MD
A study that tested 4 grams of EPA in people with heart disease or diabetes and elevated triglycerides, showing spectacular results in reducing cardiovascular events.
#129 - Tom Dayspring, M.D.: The latest insights into cardiovascular disease and lipidology
Peter Attia MD
A major clinical trial in which Amarin's branded EPA medication (Vascepa) at a high dose (4 grams/day) showed a nearly 30% reduction in residual cardiovascular risk in high-risk patients already on statins with elevated triglycerides.
#83 – Bill Harris, Ph.D.: Omega-3 fatty acids
Peter Attia MD
A landmark clinical trial that showed a 25% reduction in cardiovascular events over 5 years with 4 grams of pure EPA (Vascepa) daily in statin-treated patients with elevated triglycerides and other risk factors, with virtually no side effects.